Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Digital Health Trends 2024 - Implications for Research and Patient Care

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience Solutions with Apple devices
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE

Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions with Apple devices

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Blog
US Cold & Flu season slows in early Jan
Matt Stewart, Global Marketing Manager, IQVIA MedTech
Feb 10, 2023
  • Blogs
  • US Cold & Flu season slows in early Jan

After a rapid start, with record levels of flu incidences over the baseline 3-year average according to IQVIA’s FAN Flu/Cold/Respiratory Activity Notification Program in the fall and early winter, the cough, cold and flu (CCF) season in the world’s biggest OTC market has taken a dip.

In final week of 2022, the estimated level of total influenza cases in the US was 2.1-times the same level of the corresponding week of the baseline period – three-year average of 2016/17, 2017/18, 2018/19, - further strengthening the likelihood that we are experiencing unusually high levels of incidence over the total season, however by mid-January a slow down had taken full effect with illnesses trending in line with the most recent 3-year seasonal average (see Exhibit 1).

Despite the tail off, the early season boom in incidences meant the Q4 levels were 42% up on what was an unusually mild 2021/2022 season.

Exhibit 1 – Estimated number of total US influenza cases 2012-2022 through the week ending 14 Jan 2022 (Source: IQVIA Consumer Health FAN; IQVIA Institute)

 

This drop off brings the US season in line to the one witnessed in Australia, which started fast but then dropped off rapidlyi.

Pediatric levels still elevated

The level of influenza incidence in children remains at elevated levels, but we are seeing this tail off, with incidences in the most recent week of 14 January down by 42% over the prior 2 weeks (see Exhibit 2). This comes after a Q4 which had trended 28.9% higher than the prior year Q4. As the season enters the later stages, pediatric incidences have now sharply dipped down to the 3-year season average.

Exhibit 2 – Estimated number of total US pediatric influenza cases 2012-2022 through the week ending 14 Jan 2022 (Source: IQVIA Consumer Health FAN; IQVIA Institute)

 

A rise is on the cards

However, over the next couple of weeks both adult and pediatric incidences should start to trend over the last two seasons and this trend should continue through February and March.

Regional illness levels continue to be very different across the US, so when looking ahead Brand Managers should evaluate where they should be investing their promotional dollars to get the best ROI as the CC&F season runs out.

Keep an eye out in the coming months for IQVIA Consumer Health’s round-up of the 2022/2023 cough, cold and flu season and preview to the upcoming US allergy season and for more information on IQVIA’s FAN Flu/Cold/Respiratory Activity Notification Program please contact: Chip Schaible - chip.schaible@iqvia.com

i IQVIA Consumer Health QuickView – 2022 US Cold and Flu Season Starts with a Bang

Related solutions

Industry Segments

See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.

Contact Us